Angelyn Anton
Level 4, 8 Arnold St
Box Hill, VIC 3128, Australia
Box Hill, VIC 3128, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).
Journal: ESMO real world data and digital oncology
Published: February 27, 2026
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.
Journal: The Lancet. Oncology
Published: October 07, 2025
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in Australia.
Journal: BJUI compass
Published: July 20, 2025
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Journal: Asia-Pacific journal of clinical oncology
Published: April 23, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study.
Journal: Clinical genitourinary cancer
Published: December 03, 2024
The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian Database.
Journal: Frontiers in oncology
Published: September 10, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
Journal: JCO oncology practice
Published: May 28, 2024
Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.
Journal: Journal of geriatric oncology
Published: April 11, 2023
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 21, 2022
Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer.
Journal: BJU international
Published: November 13, 2022
Last Updated: 09/26/2026